Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Site-directed RNA editing by harnessing ADARs: advances and challengesFunctional & Integrative Genomics, 2022
- Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeuticsDrug Metabolism and Pharmacokinetics, 2022
- Prevalence of Alpha-1 Antitrypsin Deficiency, Self-Reported Behavior Change, and Health Care Engagement Among Direct-to-Consumer Recipients of a Personalized Genetic Risk ReportChest, 2022
- Liver disease in adults with severe alpha-1-antitrypsin deficiencyJournal of Gastroenterology, 2019
- Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency PhenotypeEBioMedicine, 2018
- How do ADARs bind RNA? New protein‐RNA structures illuminate substrate recognition by the RNA editing ADARsBioEssays, 2017
- Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNAJournal of Controlled Release, 2016
- The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor GrooveCell, 2010
- Alpha-1 antitrypsin Null mutations and severity of emphysemaRespiratory Medicine, 2008
- Structure and Specific RNA Binding of ADAR2 Double-Stranded RNA Binding MotifsStructure, 2006